Summary
The histologic grade of regression of 50 osteosarcomas after polychemotherapy — according to the protocol study, COSS 80 — was classified on a six-stage regression scale; 56% of all patients responded well to chemotherapy regression grades I, II, and III and no significant difference between BCD- and CPL-treated patients could be found. Tumors under 10 cm in length responded better to chemotherapy than those of greater length and there was a good correlation between the clinical estimation of tumor regression and progression and the histologic grade of regression.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Delling G (1972) Über eine vereinfachte Methacrylateinbettung für unentkalkte Knochenschnitte. Beitr Pathol 145:100–105
Delling G, Krumme H, Salzer-Kuntschik M (1983) Morphologic changes in osteosarcoma after chemotherapy — COSS 80. J Cancer Res Clin Oncol 106(Suppl):32–37
Huvos AG, Rosen R, Marcove RC (1977) Primary osteogenic sarcoma. Arch Pathol Lab Med 101:14–18
Kotz R (1978) Osteosarkom 1978. Die Wende der Prognose durch adaequate Chirurgie und adiuvante Chemotherapie. Wien Klin Wochenschr (Suppl) 90:93
Kotz R, Becker W, Immenkamp M (1983) Surgical treatment in the COSS 80 study. J Cancer Res Clin Oncol 106(Suppl):8–10
Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC (1976) Chemotherapy, en block resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37:1–11
Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230
Salzer-Kuntschik M, Delling G, Brand G (1983) Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren. Pathologe 4:135–141
Winkler K et al. (1983) Adjuvant chemotherapy in osteosarcoma — Effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study. J Cancer Res Clin Oncol 106(Suppl):1–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salzer-Kuntschik, M., Delling, G., Beron, G. et al. Morphological grades of regression in osteosarcoma after polychemotherapy — Study COSS 80. J Cancer Res Clin Oncol 106 (Suppl 1), 21–24 (1983). https://doi.org/10.1007/BF00625047
Issue Date:
DOI: https://doi.org/10.1007/BF00625047